Articles tagged with Cancer
Researchers at Penn Engineering and PSOM will develop AI systems to predict treatment response in breast cancer, heart attacks, and sepsis. The goal is to support clinicians with accurate and transparent predictions, leading to better health outcomes for patients.
Researchers found that multi-source data linkage enhances reliability of population-based cancer survival estimates in a metropolitan Chinese cancer registry. The study's findings have significant public health implications for optimizing cancer patient follow-up strategies in China and other developing countries.
The developed pipeline, NeoDisc, integrates molecular and genetic analyses of tumors and utilizes artificial intelligence algorithms to identify personalized neoantigens for vaccine design. Researchers also show that NeoDisc provides a more accurate selection of effective cancer antigens than current computational tools.
A study by Ludwig Cancer Research reveals that the most common type of DNA mutation contributing to genetic diseases is primarily caused by errors during cell division. The team found that a key component of the cell's DNA-copying machinery makes editing mistakes when encountering methylated cytosines, leading to mutations.
Aerobic physical activity was associated with modest short-term and long-term reductions of depression among adults with cancer. The study suggests that aerobic exercise may be an effective strategy for managing depression in cancer patients.
A new study found that 5-fluorouracil kills cells by interfering with RNA synthesis, not DNA damage. The findings suggest that combining 5-FU with drugs affecting RNA synthesis could make it more effective in patients with gastrointestinal cancers.
Adult childhood cancer survivors experience elevated fear of cancer recurrence, emphasizing the importance of routine screening and timely symptom intervention. The study's findings suggest that fear of cancer recurrence should be a significant concern in survivorship care.
A recent study published in Liver Cancer found that patients with diabetes mellitus and comorbid obesity are at a higher risk of liver cancer recurrence after resection. The risk is significantly higher for those with comorbid obesity, increasing by approximately 3.8 times over five years postoperatively.
Researchers developed a microchip that captures exosomes from blood plasma to identify signs of lung cancer, achieving 10x faster detection and 14x greater sensitivity. The chip uses twisted gold nanoparticles to distinguish between healthy patients and those with lung cancer.
A study from UChicago scientists reveals a significant role of RNA in DNA packaging and storage through the gene TET2. This pathway explains why many cancers involve TET2-related mutations and offers new targets for treatments. The discovery also sheds light on the connection between TET2 mutations and increased risks of heart disease,...
A study by Osaka Metropolitan University found that ChatGPT's diagnostic performance for brain tumors was comparable to that of neuroradiologists, with an accuracy rate of 73%. The model's performance varied depending on the type of clinical report written, with higher accuracy when using reports from neuroradiologist writers.
Scripps Research scientists develop a new approach to designing drugs that selectively bind to cancer-related proteins and their paralog counterparts. By identifying a druggable site on the paralog, they characterize drugs that only bind to the protein of interest, potentially leading to more effective treatments for certain cancers.
Researchers created the largest atlas of how tumor architecture changes in response to immune checkpoint therapy. The study found that multiple T cells recognize different neoantigens, altering the tumor ecosystem, and challenged prevailing theories on immunotherapy.
Researchers explore immune activation and tumor-promoting transcription factor FOXM1's role in CDK4/6-MEK resistance. They suggest targeting the oncogenic network of CDK4/6, MEK, PD-L1, and FOXM1 as future treatment options for MPNST patients.
The study found that progress in reducing excess mortality among Black individuals was stalled by an increase in mortality from external causes. Cardiovascular diseases, diabetes, and certain cancers still pose significant health risks to the US Black population.
A new study found that over a dozen bacterial species in the oral microbiome are linked to a 30-50% increased chance of developing head and neck squamous cell carcinoma. The research analyzed data from 159,840 Americans and identified key bacteria that may contribute to the disease.
Researchers developed a new mouse model to study prostate cancer spread, using CRISPR technology. The model revealed the routes of metastasis and patterns in cell seeding, providing valuable insights for better treatments.
A phase 1b/2 clinical trial found a combination of immunotherapy and FGFR inhibitor to be safe and tolerable in patients with locally advanced or metastatic bladder cancer. The treatment showed increased response rates, including 54% for patients with high FGFR mRNA expression.
Researchers found that humorous comic strip cartoons increased likelihood of agreeing to take a quiz on personal risk for colon cancer. Exposing people to funny content reduced information avoidance, making them more likely to choose to watch a video about colorectal cancer prevention.
A study by IRB Barcelona researchers has identified five independent factors that determine patients' response and survival after receiving checkpoint inhibitors, a type of immunotherapy. These findings provide a framework for current and future biomarkers of immunotherapy response and could lead to more accurate patient classification.
A study published in JAMA Network Open found that body mass index (BMI) has a more complex relationship with mortality risk during cancer therapy than previously thought. For patients with advanced non-small cell lung cancer, higher BMI was associated with lower mortality when undergoing immunotherapy or conventional chemotherapy. Howe...
A new study by Michigan Medicine found that the Inflation Reduction Act's limit on Medicare Part D spending leads to significant savings for cancer patients prescribed oral chemotherapy. The average annual cost for these medications decreased from $11,284 in 2023 to $3,927 in 2024, resulting in median cost savings of $7,260.
Researchers have discovered that fibrotic scarring enables the regrowth of tumors after aggressive brain cancer glioblastoma multiforme (GBM) treatment. Blocking fibrosis with anti-fibrosis agents could help prevent relapse and improve therapy outcomes.
A new study has identified NSD2 as a fundamental factor in early stages of prostate cancer development, found to alter androgen receptor function leading to rapid cell division and growth. The study may suggest a new way to therapeutically target prostate cancer by targeting the epigenetic component NSD2.
A recent study in Sweden found a significant decline in both melanoma incidence and mortality among individuals aged 30-49. The causes of this downward trend are unclear but may be attributed to increased UV protection, public health campaigns, demographic changes, or advancements in melanoma treatment.
The COVID-19 pandemic has led to a decrease in cancer diagnosis rates in the US, according to a new study. Despite improved trends in 2021, the rates remain lower than expected, exacerbating the existing deficit of diagnosed cases from 2020.
A new University of Kentucky study reveals that cancer diagnosis rates in the US dropped in 2021, exacerbating the pandemic-induced backlog of undiagnosed cases. The findings highlight the ongoing impact of COVID-19 on cancer care in the country.
Using tartrazine, researchers create transparency in tissues by matching refractive indices, revealing hidden organs and structures. This technique has implications for diagnosing injuries, digestive disorders, and cancers.
Researchers at Heriot-Watt University are developing a new method to process blood samples and detect cancerous DNA, which could reduce the need for painful biopsy surgery. The MicroSNARE project aims to further develop a technique to diagnose, analyse and characterise tumours earlier and detect recurrence before it spreads.
Researchers at Auburn University have developed a novel approach integrating artificial intelligence with molecular dynamics simulations and network analysis to enhance the prediction of binding sites on the PD-L1 protein. Their findings could improve immunotherapies like pembrolizumab, revolutionizing cancer treatment.
Non-Communicable Diseases (NCDs) are a major global health issue, characterized by their chronic nature and long-term impact on quality of life. In China, understanding the extent and distribution of NCDs is essential for developing effective public health strategies.
Researchers discovered hundreds of potential new cancer driver genes through splicing analysis, expanding therapeutic targets. The study found little overlap between splicing and mutation-driven cancer drivers, revealing a new class of potential cancer drivers that can be targeted independently.
Researchers developed a novel compound to target prostate cancer using radioactive atom astatine-211, potentially overcoming issues with previous compounds like deastatination. The study found high accumulation in tumors and low accumulation in vital organs, highlighting the potential of this new compound for targeted alpha therapy.
Researchers analyzed young and aged dermal fibroblasts, finding a significant decrease in protein secretion with age. The study also revealed an increase of over 60% in cytoplasmic protein accumulation, highlighting the cytoskeleton's crucial role in skin aging.
A recent study reveals racial disparities in cancer stage at diagnosis and survival for adolescents and young adults, highlighting the need for tailored interventions to achieve cancer care equity. The findings support health policy and funding implications, emphasizing the importance of addressing these disparities.
Researchers at Osaka Metropolitan University found compounds in nucleic acids from salmon DNA and torula yeast RNA inhibit cancer cell growth. These compounds may prevent cancer by stopping cell replication.
Two studies reveal key proteins involved in micronuclear collapse, including p62 and CHMP7, which can serve as prognostic markers and therapeutic targets for high-CIN tumors. Oxidative damage from ROS triggers the process, causing chromosomal instability and DNA damage that fuels cancer progression.
Researchers have found that natural killer cells instinctively recognize and attack the XPO1 protein, which drives cancer growth. By targeting this protein, scientists may be able to activate more killer cells to destroy cancer cells. The study suggests that this approach could lead to personalized cancer treatment with less side effects.
Researchers at Cold Spring Harbor Laboratory have discovered a strategy to kill breast cancer cells and shrink tumors by depriving them of two vital nutrients: glutamine and its backup supply, alpha-ketoglutarate. This approach was successful in lab experiments and effective in treating tumors in mice.
A simple blood test could identify individuals with type 2 diabetes who are at a higher risk of certain cancers. The study found that higher levels of pro-inflammatory cytokine interleukin-6 were associated with an increased risk of obesity-related cancers.
Researchers developed AI tool AINU to differentiate cancer cells from normal cells and detect early stages of viral infection. The tool scans high-resolution images of cells at nanoscale resolution, enabling it to detect subtle changes in cell structure that are too small for human observers.
A study found that counties with higher levels of structural racism had a 7.8-times higher estimated risk of developing cancer from traffic-related air pollutants, emphasizing the need for policies to address racial inequalities in exposure to carcinogenic traffic pollution.
A team of chemists at Scripps Research has mapped over 300 small molecule-reactive cancer proteins and their binding sites, revealing key protein targets that can be disrupted with certain chemical compounds to halt cancer cell growth. The findings have the potential to lead to more effective and precise cancer treatments.
A Ludwig Cancer Research study has identified PPARβ/δ, a master regulator of gene expression, as essential to the generation of memory T cells, which confer lasting immunity. The study also shows that the switch's dysfunction compromises T cell 'memory' and anti-cancer immune responses in mice.
A new treatment approach has been confirmed effective in a major study, showing that locally advanced rectal cancer patients can experience complete tumour disappearance without needing surgery. This method reduces the risk of recurrence and preserves normal bowel function, offering a promising alternative to traditional treatments.
A computational model can predict which drugs will be most effective in treating diseases caused by mutations that bring protein synthesis to a halt. The predictive model, RTDetective, accelerates the design, development, and efficacy of clinical trials for genetic disorders and cancers.
Researchers have identified HLA-E as a critical negative regulator of NK cell interactions with cancer cells. Disrupting NKG2A:HLA-E interactions may stimulate both NK cell and cytotoxic T cell effector functions against cancer, offering a promising anti-cancer strategy.
A new study reveals that fasting helps regenerate and heal intestinal injuries, but also increases the risk of developing early-stage intestinal tumors in mice. The researchers identified a pathway enabling this enhanced regeneration, which is activated during refeeding after fasting.
A cross-sectional study found that approximately 50% of cancer survivors experience financial hardship, with social vulnerability playing a key role in increasing levels of hardship. Younger, Medicare or Medicaid beneficiaries, and those with advanced disease are particularly vulnerable to financial strain.
Researchers developed alternative criteria using a prediction model to identify people with the most to gain from lung cancer screening. The study found that high-benefit groups include those who smoked for a long duration but at a lower intensity, heavy smokers who quit over 15 years ago, and racial and ethnic minority groups.
Researchers explore the phenomenon of liquid-liquid phase separation (LLPS) in relation to cancer and neurodegenerative diseases. LLPS is characterized by the spontaneous formation of segregated liquid-phase regions within cells, which can lead to the formation of aggregates and dysregulation of signaling pathways.
Researchers report a case of undifferentiated spindle cell sarcoma with primary insensitivity to standard chemotherapy, but a pronounced response to BRAF/MEK inhibitors at recurrence. The tumor was found to be BRAF exon 15 double-mutated: c.1799T>A p.V600E and c.1819T>A p.S607T.
A Rice University-led team is developing an affordable system to improve tumor removal accuracy for breast and head and neck cancer. The AccessPath system enables rapid, automatic tumor margin classification, revolutionizing real-time surgical guidance.
A new study provides a detailed map of healthy breast cells, shedding light on how breast cancer develops and the genetic ancestry-dependent variability in breast tissue. The research aims to identify new treatment targets and improve understanding of breast cancer development.
A cohort study found an association between cannabis-related disorder and the development of head and neck cancer. The study highlights the need for further research on the mechanism of this association and dose response to support evidence of cannabis use as a risk factor.
A recent study found that nearly half of cancer institutions lack adequate translation services, leading to difficulties recruiting minority patients. The study highlights the need for improved language equity in clinical trials to ensure equitable access to treatments.
A modeling study estimates that cancer screening costs over $40 billion annually in the US, with an emphasis on enhancing equitable access to recommended screenings. However, experts argue that this estimate may underestimate the true cost due to lack of consideration for subsequent testing, ineligible patients, and overdiagnosis.
A cohort study found that aspirin use was associated with a greater absolute reduction in risk of colorectal cancer among individuals with less healthy lifestyles. Lifestyle risk factors may help identify those with a more favorable risk-benefit profile for cancer prevention with aspirin.
Researchers predict that circular RNAs will play a crucial role in cancer diagnosis and treatment, enabling innovative diagnostic and therapeutic developments. The study highlights the potential of circRNAs as biomarkers, therapy targets, and even immune response inducers against cancer cells.
Researchers identified areas with lower colorectal cancer screening rates and developed an interactive web map to pinpoint neighborhood-level disparities. The study aims to inform targeted education or intervention programs, ultimately increasing screening rates in priority neighborhoods and contributing to national improvements.